WuXi News
Dr. Ge Li Receives Executive of the Year Award from SCRIP

WuXi and MedImmune Form Strategic Alliance to Develop Innovative Biologics in China for AstraZeneca
 
WuXi and Lilly Collaborate to Develop Novel Therapeutics in China
WuXi Global Forum 2016 at J.P. Morgan Conference
 
WuXi Healthcare Ventures II Closes with Oversubscription

Gilead Sciences and WuXi Partner for a Dedicated Analytical and Stability Testing Facility
 
Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project
Congratulations to Novira Therapeutics for its Acquisition Agreement with Johnson & Johnson
 
Innovation That Matters
Combating the Hep B Virus: An Interview with George Hartman, Novira Therapeutics
Perspectives
Combining Service and Investment: An Interview with Wei Li, Co-Founder of WuXi Healthcare Ventures
Developing a Novel ADC for Global Market via Innovative Three-party Collaboration - An Interview with Dr. Jiawen Han, VP of WuXi Biologics
Prospects for Cell and Gene Therapy: An Interview with Alan Moore, VP of Strategic Accounts and Cell Manufacturing
Meet IDSU Leadership: An Interview with Tao Guo, VP of Medicinal Chemistry
In This Issue:
 
Industry Beats
FDA Approvals & Designations
 
Upcoming Events
January 12, 2016
DNC Auditorium 
The Scripps Research Institute

January 20-22, 2016
Salk Institute

February 24, 2016
The Lodge at Torrey Pines
 
WuXi AppTec
9765 Clairemont Mes Blvd
San Diego, CA
858-622-0099  
Follow us on Twitter View our profile on LinkedIn

Confirm that you like this.

Click the "Like" button.